SpectraBase Spectrum ID |
8JbhvYf3LNY |
Name |
Embutramide |
CAS Registry Number |
15687-14-6 |
Classification |
Pharmaceutical drug, narcotic analgesic |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (5) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Embutramide |
DEA Controlled Substances Code Number |
2020 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
293.199093730 u |
Formula |
C17H27NO3 |
InChI |
InChI=1S/C17H27NO3/c1-4-17(5-2,13-18-16(20)10-7-11-19)14-8-6-9-15(12-14)21-3/h6,8-9,12,19H,4-5,7,10-11,13H2,1-3H3,(H,18,20) |
InChIKey |
LMBMDLOSPKIWAP-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
293.407 g/mol |
Nominal Mass |
293 u |
Quality |
996 |
Retention Index |
2210 |
SMILES |
OCCCC(NCC(C1=CC(=CC=C1)OC)(CC)CC)=O |
SPLASH |
splash10-000x-3900000000-96db0b78751a1a696053 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
N-[2-Ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxy-butanamide |
Technique |
GC/MS |
Wiley ID |
DD2024_001276 |